L1 Capital Pty Ltd Sells 23,000 Shares of Anteris Technologies Global (NASDAQ:AVR) Stock

Anteris Technologies Global Corp. (NASDAQ:AVR) major shareholder L1 Capital Pty Ltd sold 23,000 shares of Anteris Technologies Global stock in a transaction that occurred on Friday, July 24th. The shares were sold at an average price of $8.13, for a total value of $186,990.00. Following the transaction, the insider owned 7,789,000 shares of the company’s stock, valued at approximately $63,324,570. This represents a 0.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Anteris Technologies Global Price Performance

NASDAQ AVR traded down $0.05 during trading hours on Tuesday, hitting $8.12. 776,846 shares of the company’s stock traded hands, compared to its average volume of 1,184,677. The firm’s 50-day moving average is $9.27 and its 200-day moving average is $7.07. The company has a market capitalization of $790.50 million, a PE ratio of -3.62 and a beta of 1.65. Anteris Technologies Global Corp. has a 52-week low of $2.99 and a 52-week high of $11.06.

Anteris Technologies Global (NASDAQ:AVR) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The business had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.77 million. Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.During the same period in the previous year, the business posted ($0.61) earnings per share. Equities research analysts predict that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Anteris Technologies Global

Several large investors have recently made changes to their positions in AVR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Anteris Technologies Global during the 1st quarter valued at $32,000. Geode Capital Management LLC raised its stake in shares of Anteris Technologies Global by 154.3% in the second quarter. Geode Capital Management LLC now owns 420,427 shares of the company’s stock valued at $1,593,000 after purchasing an additional 255,088 shares in the last quarter. JPMorgan Chase & Co. grew its position in Anteris Technologies Global by 9,958.6% in the second quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock valued at $4,049,000 after acquiring an additional 1,057,707 shares during the period. Nantahala Capital Management LLC raised its stake in shares of Anteris Technologies Global by 1.8% in the second quarter. Nantahala Capital Management LLC now owns 1,693,666 shares of the company’s stock valued at $6,419,000 after acquiring an additional 30,000 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Anteris Technologies Global by 85.1% during the third quarter. Vanguard Group Inc. now owns 745,560 shares of the company’s stock worth $3,355,000 after purchasing an additional 342,711 shares during the last quarter.

Analysts Set New Price Targets

Several research firms recently commented on AVR. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Barclays raised their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Anteris Technologies Global currently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.